Molina Healthcare Got Some Bad News

By Austin Angelo

Stifel Nicolaus analyst Thomas Carroll downgraded Molina Healthcare (NYSE: MOH) to Sell today and set a price target of $60. The company’s shares closed yesterday at $66.30, close to its 52-week high of $68.67.

According to TipRanks.com, Carroll is a 5-star analyst with an average return of 16.1% and a 84.0% success rate. Carroll covers the Healthcare sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Express Scripts.

Molina Healthcare has an analyst consensus of Hold, with a price target consensus of $59.17.

The company has a one year high of $68.67 and a one year low of $42.56. Currently, Molina Healthcare has an average volume of 1.52M.

Based on the recent corporate insider activity of 104 insiders, corporate insider sentiment is negative on the stock. Earlier this month, Garrey Carruthers, a Director at MOH sold 2,850 shares for a total of $191,349.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Molina Healthcare, Inc. engages in the provision of managed health care services. It operates through the following segments: Health Plans, Molina Medicaid Solutions, and Others. The Health Plans segment consists of operational health plans. The Molina Medicaid Solutions segment involves in the design, development, implementation, and business process outsourcing solutions to state governments for their medicaid management information systems. The Others segment includes pathways behavioral health and social services provider. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.